Log In
Wednesday 26th June 2019

Anti-TNF drugs may reduce RA patients' risk of diabetes

24th June 2011

Anti-rheumatic drugs could help lower the risk of people developing diabetes.

People with systemic inflammatory conditions, such as rheumatoid arthritis or psoriasis, have previously been shown to have a higher-than-average risk of developing diabetes. But taking certain disease-modifying anti-rheumatic drugs (DMARDs), including anti-tumour necrosis factor (anti-TNF) therapy and a drug called hydroxychloroquine, may help to lower this risk.

Arthritis Research UK said the work highlighted that it is vital that many of the exciting new drugs should not only be monitored for previously unrecognised side effects “but also for new and unexpected treatment benefits in other conditions.”


Share this page


There are no comments for this article, be the first to comment!

Post your comment

Only registered users can comment. Fill in your e-mail address for quick registration.

Your email address:

Your comment will be checked by a Healthcare Today moderator before it is published on the site.

Mayden - Innovative cloud-based web development for the healthcare sector
© Mayden Foundation 2019